193 related articles for article (PubMed ID: 28423692)
21. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways.
Maroufi NF; Vahedian V; Akbarzadeh M; Mohammadian M; Zahedi M; Isazadeh A; Pouremamali F; Taefehshokr S; Heidari M; Rashidi M; Nouri M
Breast Cancer; 2020 Jul; 27(4):613-620. PubMed ID: 32026267
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
23. Differential involvement of TAK1, RIPK1 and NF-κB signaling in Smac mimetic-induced cell death in breast cancer cells.
Schmidt N; Kowald L; van Wijk SJL; Fulda S
Biol Chem; 2019 Jan; 400(2):171-180. PubMed ID: 30391931
[TBL] [Abstract][Full Text] [Related]
24. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
Veuger SJ; Durkacz BW
DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
[TBL] [Abstract][Full Text] [Related]
25. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.
Singh S; Shi Q; Bailey ST; Palczewski MJ; Pardee AB; Iglehart JD; Biswas DK
Mol Cancer Ther; 2007 Jul; 6(7):1973-82. PubMed ID: 17620428
[TBL] [Abstract][Full Text] [Related]
26. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway.
Wang G; Li J; Zhang L; Huang S; Zhao X; Zhao X
Biochem Biophys Res Commun; 2017 Aug; 490(3):969-976. PubMed ID: 28666869
[TBL] [Abstract][Full Text] [Related]
27. Relationship between NF-κB, ER, PR, Her2/neu, Ki67, p53 expression in human breast cancer.
Shapochka DO; Zaletok SP; Gnidyuk MI
Exp Oncol; 2012 Dec; 34(4):358-63. PubMed ID: 23302996
[TBL] [Abstract][Full Text] [Related]
28. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes.
Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA
Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931
[TBL] [Abstract][Full Text] [Related]
29. Antiapoptotic effects of progastrin on pancreatic cancer cells are mediated by sustained activation of nuclear factor-{kappa}B.
Rengifo-Cam W; Umar S; Sarkar S; Singh P
Cancer Res; 2007 Aug; 67(15):7266-74. PubMed ID: 17671195
[TBL] [Abstract][Full Text] [Related]
30. Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancer.
Byron SA; Min E; Thal TS; Hostetter G; Watanabe AT; Azorsa DO; Little TH; Tapia C; Kim S
PLoS One; 2012; 7(10):e46823. PubMed ID: 23056468
[TBL] [Abstract][Full Text] [Related]
31. Notch-1 signaling activates NF-κB in human breast carcinoma MDA-MB-231 cells via PP2A-dependent AKT pathway.
Li L; Zhang J; Xiong N; Li S; Chen Y; Yang H; Wu C; Zeng H; Liu Y
Med Oncol; 2016 Apr; 33(4):33. PubMed ID: 26945854
[TBL] [Abstract][Full Text] [Related]
32. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway.
Pan H; Zhou W; He W; Liu X; Ding Q; Ling L; Zha X; Wang S
Int J Mol Med; 2012 Aug; 30(2):337-43. PubMed ID: 22580499
[TBL] [Abstract][Full Text] [Related]
33. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
34. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
35. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
[TBL] [Abstract][Full Text] [Related]
36. Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma.
Rojo F; González-Pérez A; Furriol J; Nicolau MJ; Ferrer J; Burgués O; Sabbaghi M; González-Navarrete I; Cristobal I; Serrano L; Zazo S; Madoz J; Servitja S; Tusquets I; Albanell J; Lluch A; Rovira A; Eroles P
Br J Cancer; 2016 Jul; 115(3):322-31. PubMed ID: 27404455
[TBL] [Abstract][Full Text] [Related]
37. TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activation.
Bonif M; Meuwis MA; Close P; Benoit V; Heyninck K; Chapelle JP; Bours V; Merville MP; Piette J; Beyaert R; Chariot A
Biochem J; 2006 Mar; 394(Pt 3):593-603. PubMed ID: 16336209
[TBL] [Abstract][Full Text] [Related]
38. The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer.
Gujam FJ; Edwards J; Mohammed ZM; Going JJ; McMillan DC
Br J Cancer; 2014 Jul; 111(1):157-65. PubMed ID: 24874480
[TBL] [Abstract][Full Text] [Related]
39. A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.
Wu H; Wang G; Wang Z; An S; Ye P; Luo S
FEBS J; 2016 Jun; 283(12):2259-71. PubMed ID: 26433127
[TBL] [Abstract][Full Text] [Related]
40. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
